Orthopedic Joint & Tendon Injections (Viscosupplementation)

Orthopedic injections deliver hyaluronic acid and cross-linked collagen directly into a painful joint or tendon to relieve pain, support mobility and help slow degenerative change. This viscosupplementation lubricates and cushions the joint while the collagen supports tissue repair. At GH Solutions the injections are performed by a specialist physician for arthritis, tendon inflammation and post-injury recovery, with effect lasting six to twelve months.

Beyond aesthetics, GH Solutions offers physician-performed orthopedic injections aimed at joint and tendon pain. The core technique is viscosupplementation: injecting hyaluronic acid — the same lubricating molecule found naturally in joint fluid — into a joint affected by osteoarthritis or wear. In a healthy joint, hyaluronic acid gives the synovial fluid its cushioning, shock-absorbing properties; in an arthritic joint this fluid thins, so supplementing it can reduce friction, ease pain and improve mobility. GH Solutions combines this with cross-linked collagen to support the surrounding connective tissue and tendon. The treatment is delivered by a specialist physician in the Blue House clinic at Spa Resort Sanssouci and is used for osteoarthritis, tendon inflammation (tendinopathy) and recovery after injury, as well as for prevention in joints showing early wear. The appointment, lasting around fifteen to thirty minutes including consultation, begins with an assessment of the affected joint or tendon and the most appropriate substance. The skin is cleansed and the solution is injected precisely into the joint space or around the tendon using a sterile technique. You may feel temporary fullness or mild discomfort in the joint afterwards, and you'll typically be advised to avoid heavy loading of the joint for a day or two. Pain relief and improved movement usually build over the following days to weeks, with the benefit of a course generally lasting six to twelve months before it is repeated. Contraindications screened at consultation include active joint infection, skin infection over the injection site and known allergy to the product.